ReviewCureus2022

Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients With Diabetes and Chronic Kidney Disease (CKD): A Meta-analysis of Randomized Control Trials.

Sidra Jamil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.